Targeted high-level production of chuangxinmycin and its halogenated derivatives with antitubercular activity

Synthetic biology techniques are well-suited for the targeted and high-level biosynthesis of CM and its derivatives. This study reports the highest laboratory-level yields of CM and NCM to date. This is the first instance of obtaining CM derivatives by biosynthesis rather than chemical synthesis, and it also marks the first report of halogenated NCM derivatives. High-level production of CM and its diverse analogues will provide a solid material foundation for advancing CM and its derivatives as potential anti-tuberculosis drug candidates.

Authors

Institutions

Publication Details

Journal
Microbial Cell Factories
Published
2025-05-19
DOI
https://doi.org/10.1186/s12934-025-02740-x
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted high-level production of chuangxinmycin and its halogenated derivatives with antitubercular activity

Bin Hong, Yuanyuan Shi, Xingli Han, Xingquan Zhao et al.
Microbial Cell Factories
Microbial Natural Products and Biosynthesis
article

Targeted high-level production of chuangxinmycin and its halogenated derivatives with antitubercular activity

Bin Hong, Yuanyuan Shi, Xingli Han, Xingquan Zhao, Tianyu Zhang, Xintong Zhang, Xingxing Li, Yuan Lu, Yu Du, Xiumin Zhang, Linzhuan Wu, Yuting Zhu, Wei Yu
article en

Abstract

Synthetic biology techniques are well-suited for the targeted and high-level biosynthesis of CM and its derivatives. This study reports the highest laboratory-level yields of CM and NCM to date. This is the first instance of obtaining CM derivatives by biosynthesis rather than chemical synthesis, and it also marks the first report of halogenated NCM derivatives. High-level production of CM and its diverse analogues will provide a solid material foundation for advancing CM and its derivatives as potential anti-tuberculosis drug candidates.

Microbial Cell FactoriesVol. 24(1)
University of Science and Technology of China (CN), Chinese Academy of Sciences (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Guangzhou Institutes of Biomedicine and Health (CN), State Key Laboratory of Respiratory Disease (CN), University of Chinese Academy of Sciences (CN)
National Natural Science Foundation of China, Beijing Nova Program, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 87%
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Targeted high-level production of chuangxinmycin and its halogenated derivatives with antitubercular activity — Bin Hong, Yuanyuan Shi, et al. · Microbial Cell Factories (2025) | TGRS Research Map | TGRS